{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cerebellum", "degeneration", "inflammasome", "methamphetamine", "motor deficit"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35431795", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "01"}], "Language": ["eng"], "ELocationID": ["861340", "10.3389/fnmol.2022.861340"], "Journal": {"ISSN": "1662-5099", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in molecular neuroscience", "ISOAbbreviation": "Front Mol Neurosci"}, "ArticleTitle": "Inflammasome Inhibition Prevents Motor Deficit and Cerebellar Degeneration Induced by Chronic Methamphetamine Administration.", "Pagination": {"StartPage": "861340", "MedlinePgn": "861340"}, "Abstract": {"AbstractText": ["Methamphetamine (METH), a psychostimulant, has the potential to cause neurodegeneration by targeting the cerebrum and cerebellum. It has been suggested that the NLRP3 inflammasome may be responsible for the neurotoxicity caused by METH. However, the role of NLRP3 in METH-induced cerebellar Purkinje cell (PC) degeneration and the underlying mechanism remain elusive. This study aims to determine the consequences of NLRP3 modulation and the underlying mechanism of chronic METH-induced cerebellar PC degeneration. In METH mice models, increased NLRP3 expression, PC degeneration, myelin sheath destruction, axon degeneration, glial cell activation, and motor coordination impairment were observed. Using the NLRP3 inhibitor MCC950, we found that inhibiting NLRP3 alleviated the above-mentioned motor deficits and cerebellar pathologies. Furthermore, decreased mature IL-1\u03b2 expression mediated by Caspase 1 in the cerebellum may be associated with the neuroprotective effects of NLRP3 inflammasome inhibition. Collectively, these findings suggest that mature IL-1\u03b2 secretion mediated by NLRP3-ASC-Caspase 1 may be a critical step in METH-induced cerebellar degeneration and highlight the neuroprotective properties of inflammasome inhibition in cerebellar degeneration."], "CopyrightInformation": "Copyright \u00a9 2022 Ding, Shen, Ye, Hu, Ren, Liu, Dai, Li, Wang, Luo, Zhang, Zhang, Qi and Huang."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China."}], "LastName": "Ding", "ForeName": "Jiuyang", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medical Science, Guizhou Medical University, Guiyang, China."}], "LastName": "Shen", "ForeName": "Lingyi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, Liuzhou People's Hospital, Liuzhou, China."}], "LastName": "Ye", "ForeName": "Yuanliang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Good Clinical Practice Center, Affiliated Hospital of Zunyi Medical University, Zunyi, China."}], "LastName": "Hu", "ForeName": "Shanshan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Ren", "ForeName": "Zheng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Key Laboratory of Pharmaceutics of Guizhou Province, Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Dai", "ForeName": "Jialin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Li", "ForeName": "Zhu", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Wang", "ForeName": "Jiawen", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Luo", "ForeName": "Ya", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhang", "ForeName": "Qiaojun", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhang", "ForeName": "Xiali", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China."}], "LastName": "Qi", "ForeName": "Xiaolan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang, China."}], "LastName": "Huang", "ForeName": "Jiang", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Mol Neurosci", "NlmUniqueID": "101477914", "ISSNLinking": "1662-5099"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Aoki H., Higashi M., Okita M., Ando N., Murayama S., Ishikawa K., et al. (2022). Thymidine kinase 2 and mitochondrial protein COX I in the cerebellum of patients with spinocerebellar ataxia type 31 caused by penta-nucleotide repeats (TTCCA) n. Cerebellum. 10.1007/s12311-021-01364-2", "ArticleIdList": ["10.1007/s12311-021-01364-2", "PMC9883315", "35084690"]}, {"Citation": "Ares-Santos S., Granado N., Espadas I., Martinez-Murillo R., Moratalla R. (2014). Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology 39 1066\u20131080. 10.1038/npp.2013.307", "ArticleIdList": ["10.1038/npp.2013.307", "PMC3957101", "24169803"]}, {"Citation": "Bechet S., O\u2019sullivan S. A., Yssel J., Fagan S. G., Dev K. K. (2020). Fingolimod rescues demyelination in a mouse model of Krabbe\u2019s disease. J. Neurosci. 40 3104\u20133118. 10.1523/JNEUROSCI.2346-19.2020", "ArticleIdList": ["10.1523/JNEUROSCI.2346-19.2020", "PMC7141882", "32127495"]}, {"Citation": "Boroujeni M. E., Nasrollahi A., Boroujeni P. B., Fadaeifathabadi F., Farhadieh M., Tehrani A. M., et al. (2020). Exposure to methamphetamine exacerbates motor activities and alters circular RNA profile of cerebellum. J. Pharmacol. Sci. 144 1\u20138. 10.1016/j.jphs.2020.05.010", "ArticleIdList": ["10.1016/j.jphs.2020.05.010", "32576439"]}, {"Citation": "Chen M., Lai X., Wang X., Ying J., Zhang L., Zhou B., et al. (2021). Long Non-coding RNAs and circular RNAs: insights into microglia and astrocyte mediated neurological diseases. Front. Mol. Neurosci. 14:745066. 10.3389/fnmol.2021.745066", "ArticleIdList": ["10.3389/fnmol.2021.745066", "PMC8523841", "34675776"]}, {"Citation": "Codolo G., Plotegher N., Pozzobon T., Brucale M., Tessari I., Bubacco L., et al. (2013). Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS One 8:e55375. 10.1371/journal.pone.0055375", "ArticleIdList": ["10.1371/journal.pone.0055375", "PMC3561263", "23383169"]}, {"Citation": "Danaceau J. P., Deering C. E., Day J. E., Smeal S. J., Johnson-Davis K. L., Fleckenstein A. E., et al. (2007). Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur. J. Pharmacol. 559 46\u201354. 10.1016/j.ejphar.2006.11.045", "ArticleIdList": ["10.1016/j.ejphar.2006.11.045", "17239369"]}, {"Citation": "Ding J., Hu S., Meng Y., Li C., Huang J., He Y., et al. (2020a). Alpha-synuclein deficiency ameliorates chronic methamphetamine induced neurodegeneration in mice. Toxicology 438 152461. 10.1016/j.tox.2020.152461", "ArticleIdList": ["10.1016/j.tox.2020.152461", "32278788"]}, {"Citation": "Ding J., Lian Y., Meng Y., He Y., Fan H., Li C., et al. (2020b). The effect of alpha-synuclein and Tau in methamphetamine induced neurotoxicity in vivo and in vitro. Toxicol. Lett. 319 213\u2013224. 10.1016/j.toxlet.2019.11.028", "ArticleIdList": ["10.1016/j.toxlet.2019.11.028", "31783120"]}, {"Citation": "Du L., Shen K., Bai Y., Chao J., Hu G., Zhang Y., et al. (2019). Involvement of NLRP3 inflammasome in methamphetamine-induced microglial activation through miR-143/PUMA axis. Toxicol. Lett. 301 53\u201363. 10.1016/j.toxlet.2018.10.020", "ArticleIdList": ["10.1016/j.toxlet.2018.10.020", "30394308"]}, {"Citation": "Eskandarian Boroujeni M., Peirouvi T., Shaerzadeh F., Ahmadiani A., Abdollahifar M. A., Aliaghaei A. (2020). Differential gene expression and stereological analyses of the cerebellum following methamphetamine exposure. Addict. Biol. 25:e12707. 10.1111/adb.12707", "ArticleIdList": ["10.1111/adb.12707", "30714656"]}, {"Citation": "Falcon-Moya R., Losada-Ruiz P., Sihra T. S., Rodriguez-Moreno A. (2018). Cerebellar kainate receptor-mediated facilitation of glutamate release requires Ca(2+)-calmodulin and PKA. Front. Mol. Neurosci. 11:195. 10.3389/fnmol.2018.00195", "ArticleIdList": ["10.3389/fnmol.2018.00195", "PMC5997777", "29928192"]}, {"Citation": "Gordon R., Albornoz E. A., Christie D. C., Langley M. R., Kumar V., Mantovani S., et al. (2018). Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med. 10:eaah4066. 10.1126/scitranslmed.aah4066", "ArticleIdList": ["10.1126/scitranslmed.aah4066", "PMC6483075", "30381407"]}, {"Citation": "Holbrook J. A., Jarosz-Griffiths H. H., Caseley E., Lara-Reyna S., Poulter J. A., Williams-Gray C. H., et al. (2021). Neurodegenerative disease and the NLRP3 inflammasome. Front. Pharmacol. 12:643254. 10.3389/fphar.2021.643254", "ArticleIdList": ["10.3389/fphar.2021.643254", "PMC7987926", "33776778"]}, {"Citation": "Huang J., Yang G., Li Z., Leung C. K., Wang W., Li Y., et al. (2020). Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine-induced behavioral sensitization in tree shrews. Brain Behav. 10:e01533. 10.1002/brb3.1533", "ArticleIdList": ["10.1002/brb3.1533", "PMC7010569", "31943832"]}, {"Citation": "Kohno M., Dennis L. E., Mccready H., Hoffman W. F. (2021). Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment. Mol. Psychiatry. 10.1038/s41380-021-01180-4", "ArticleIdList": ["10.1038/s41380-021-01180-4", "PMC8664889", "34117366"]}, {"Citation": "Lamkanfi M., Dixit V. M. (2014). Mechanisms and functions of inflammasomes. Cell 157 1013\u20131022. 10.1016/j.cell.2014.04.007", "ArticleIdList": ["10.1016/j.cell.2014.04.007", "24855941"]}, {"Citation": "Li J. H., Liu J. L., Zhang K. K., Chen L. J., Xu J. T., Xie X. L. (2021). The adverse effects of prenatal METH exposure on the offspring: a review. Front. Pharmacol. 12:715176. 10.3389/fphar.2021.715176", "ArticleIdList": ["10.3389/fphar.2021.715176", "PMC8317262", "34335277"]}, {"Citation": "Lonnemann N., Hosseini S., Marchetti C., Skouras D. B., Stefanoni D., D\u2019Alessandro A., et al. (2020). The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. U.S.A. 117 32145\u201332154. 10.1073/pnas.2009680117", "ArticleIdList": ["10.1073/pnas.2009680117", "PMC7749353", "33257576"]}, {"Citation": "Martinon F., Burns K., Tschopp J. (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10 417\u2013426. 10.1016/s1097-2765(02)00599-3", "ArticleIdList": ["10.1016/s1097-2765(02)00599-3", "12191486"]}, {"Citation": "Moussaud S., Jones D. R., Moussaud-Lamodiere E. L., Delenclos M., Ross O. A., Mclean P. J. (2014). Alpha-synuclein and tau: teammates in neurodegeneration? Mol. Neurodegener. 9:43. 10.1186/1750-1326-9-43", "ArticleIdList": ["10.1186/1750-1326-9-43", "PMC4230508", "25352339"]}, {"Citation": "Nabar N. R., Kehrl J. H. (2019). Inflammasome inhibition links IRGM to innate immunity. Mol. Cell 73 391\u2013392. 10.1016/j.molcel.2019.01.029", "ArticleIdList": ["10.1016/j.molcel.2019.01.029", "30735651"]}, {"Citation": "Nobrega C., Nascimento-Ferreira I., Onofre I., Albuquerque D., Conceicao M., Deglon N., et al. (2013). Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology. Cerebellum 12 441\u2013455. 10.1007/s12311-012-0432-0", "ArticleIdList": ["10.1007/s12311-012-0432-0", "23242710"]}, {"Citation": "Qiu X., Wang Q., Hou L., Zhang C., Wang Q., Zhao X. (2021). Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson\u2019s disease model. Toxicol. Lett. 349 1\u201311. 10.1016/j.toxlet.2021.05.008", "ArticleIdList": ["10.1016/j.toxlet.2021.05.008", "34052309"]}, {"Citation": "Ramshini E., Sheykhzade M., Dabiri S., Shabani M. (2021). Cannabinoid CB1 receptor mediates METH-induced electrophysiological and morphological alterations in cerebellum Purkinje cells. Hum. Exp. Toxicol. 40 940\u2013951. 10.1177/0960327120975448", "ArticleIdList": ["10.1177/0960327120975448", "33249856"]}, {"Citation": "Rathinam V. A., Fitzgerald K. A. (2016). Inflammasome complexes: emerging mechanisms and effector functions. Cell 165 792\u2013800. 10.1016/j.cell.2016.03.046", "ArticleIdList": ["10.1016/j.cell.2016.03.046", "PMC5503689", "27153493"]}, {"Citation": "Ruan Q. T., Yazdani N., Blum B. C., Beierle J. A., Lin W., Coelho M. A., et al. (2020). A mutation in Hnrnph1 that decreases methamphetamine-induced reinforcement, reward, and dopamine release and increases synaptosomal hnRNP H and mitochondrial proteins. J. Neurosci. 40 107\u2013130. 10.1523/JNEUROSCI.1808-19.2019", "ArticleIdList": ["10.1523/JNEUROSCI.1808-19.2019", "PMC6939476", "31704785"]}, {"Citation": "Rui W., Xiao H., Fan Y., Ma Z., Xiao M., Li S., et al. (2021). Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer\u2019s disease. J. Neuroinflammation 18:280. 10.1186/s12974-021-02329-2", "ArticleIdList": ["10.1186/s12974-021-02329-2", "PMC8638109", "34856990"]}, {"Citation": "Saijo K., Winner B., Carson C. T., Collier J. G., Boyer L., Rosenfeld M. G., et al. (2009). A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137 47\u201359. 10.1016/j.cell.2009.01.038", "ArticleIdList": ["10.1016/j.cell.2009.01.038", "PMC2754279", "19345186"]}, {"Citation": "Schonewille M., Girasole A. E., Rostaing P., Mailhes-Hamon C., Ayon A., Nelson A. B., et al. (2021). NMDARs in granule cells contribute to parallel fiber-Purkinje cell synaptic plasticity and motor learning. Proc. Natl. Acad. Sci. U.S.A. 118:e2102635118. 10.1073/pnas.2102635118", "ArticleIdList": ["10.1073/pnas.2102635118", "PMC8449340", "34507990"]}, {"Citation": "Schroder K., Tschopp J. (2010). The inflammasomes. Cell 140 821\u2013832.", "ArticleIdList": ["20303873"]}, {"Citation": "Sekine Y., Ouchi Y., Takei N., Yoshikawa E., Nakamura K., Futatsubashi M., et al. (2006). Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch. Gen. Psychiatry 63 90\u2013100. 10.1001/archpsyc.63.1.90", "ArticleIdList": ["10.1001/archpsyc.63.1.90", "16389202"]}, {"Citation": "Song L., Pei L., Yao S., Wu Y., Shang Y. (2017). NLRP3 inflammasome in neurological diseases, from functions to therapies. Front. Cell. Neurosci. 11:63. 10.3389/fncel.2017.00063", "ArticleIdList": ["10.3389/fncel.2017.00063", "PMC5343070", "28337127"]}, {"Citation": "Strowig T., Henao-Mejia J., Elinav E., Flavell R. (2012). Inflammasomes in health and disease. Nature 481 278\u2013286. 10.1038/nature10759", "ArticleIdList": ["10.1038/nature10759", "22258606"]}, {"Citation": "Vasili E., Dominguez-Meijide A., Outeiro T. F. (2019). Spreading of alpha-Synuclein and Tau: a systematic comparison of the mechanisms involved. Front. Mol. Neurosci. 12:107. 10.3389/fnmol.2019.00107", "ArticleIdList": ["10.3389/fnmol.2019.00107", "PMC6494944", "31105524"]}, {"Citation": "Wagner M. J., Savall J., Hernandez O., Mel G., Inan H., Rumyantsev O., et al. (2021). A neural circuit state change underlying skilled movements. Cell 184 3731\u20133747.e21. 10.1016/j.cell.2021.06.001", "ArticleIdList": ["10.1016/j.cell.2021.06.001", "PMC8844704", "34214470"]}, {"Citation": "Yang J., Wise L., Fukuchi K. I. (2020). TLR4 cross-Talk With NLRP3 inflammasome and complement signaling pathways in Alzheimer\u2019s disease. Front. Immunol. 11:724. 10.3389/fimmu.2020.00724", "ArticleIdList": ["10.3389/fimmu.2020.00724", "PMC7190872", "32391019"]}, {"Citation": "Yin X., Zhao C., Qiu Y., Zhou Z., Bao J., Qian W. (2021). Dendritic/Post-synaptic Tau and early pathology of Alzheimer\u2019s disease. Front. Mol. Neurosci. 14:671779. 10.3389/fnmol.2021.671779", "ArticleIdList": ["10.3389/fnmol.2021.671779", "PMC8270001", "34248498"]}, {"Citation": "Zhang C., Zhao M., Wang B., Su Z., Guo B., Qin L., et al. (2021). The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson\u2019s disease. Redox Biol. 47 102134. 10.1016/j.redox.2021.102134", "ArticleIdList": ["10.1016/j.redox.2021.102134", "PMC8487081", "34600334"]}, {"Citation": "Zhang H., Hong Y., Yang W., Wang R., Yao T., Wang J., et al. (2021). SNX14 deficiency-induced defective axonal mitochondrial transport in Purkinje cells underlies cerebellar ataxia and can be reversed by valproate. Natl. Sci. Rev. 8:nwab024. 10.1093/nsr/nwab024", "ArticleIdList": ["10.1093/nsr/nwab024", "PMC8310771", "34691693"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "24"}, {"Year": "2022", "Month": "3", "Day": "3"}, {"Year": "2022", "Month": "4", "Day": "18", "Hour": "6", "Minute": "32"}, {"Year": "2022", "Month": "4", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "19", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["35431795", "PMC9010733", "10.3389/fnmol.2022.861340"]}}], "PubmedBookArticle": []}